Protein kinase C-δ is an important signaling molecule in insulin-like: Growth factor I receptor-mediated cell transformation

Molecular and Cellular Biology

Volumn 18, Issue 10, 1998, Pages 5888-5898

  Li, Weiqun ^a   Jiang, Y I Xing ^b   Zhang, Jiachang ^a   Soon, Lilian ^a   Flechner, Lawrence ^a   Kapoor, Veena ^a   Pierce, Jacalyn H ^a   Wang, Lu Hai ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0031684848     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.10.5888     Document Type: Article

References (54)

1. Arteaga, C. L. 1992. Interference of the IGF system as a strategy to inhibit breast cancer growth. Breast Cancer Res. Treat. 22:101-106.
2. Baker, J., J. P. Liu, E. J. Robertson, and A. Efstraitiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 79:927-930.
3. Baserga, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth. Cancer Res. 55:249-252.
4. Baserga, R. 1994. Oncogenes and the strategy of growth factors. Cell 79:927-930.
5. Baserga, R., A. Hongo, M. Rubini, M. Frisco, and B. Valentinis. 1997. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332:F105-F126.
6. Coppola, D., A. Ferver, M. Miura, C. Sell, C. D'Ambrosio, R. Rubin, and R. Baserga. 1994. A functional IGF-I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14:4588-4595.
7. DeAngelis, T., A. Ferber, and R. Baserga. 1995. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol. 164:214-221.
8. Denning, M. F., A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa. 1996. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C δ. J. Biol. Chem. 271:26079-26081.
9. Ha gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C δ. J. Biol. Chem. 268:26079-26081.
10. Ettinger, S. L., R. W. Lauener, and V. Duronio. 1996. Protein kinase C δ specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. J. Biol. Chem. 271:14514-14518.
11. Gschwendt, M., K. Kielbassa, W. Kittstein, and F. Marks. 1994. Tyrosine phosphorylation and stimulation of protein kinase Cδ from porcine spleen by src in vitro: dependence on the activated state of protein kinase Cδ. FEBS Lett. 347:85-89.
12. Hernandez-Sanchez, C., V. Blakesley, T. Kalebic, L. Helman, and D. Leroith. 1995. The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tomorigenesis. J. Biol. Chem. 270:29176-29181.
13. Hirai, S., Y. Izumi, K. Higa, K. Kaibuchi, K. Mizuno, S. Osada, K. Suzuki, and S. Ohno. 1994. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKCδ. EMBO J. 13:2331-2340.
14. Bajaken, S. Personal communication.
15. Jiang, Y., J. L.-K. Chan, C. S. Zong, and L.-H. Wang. 1996. Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor. J. Biol. Chem. 271:160-167.
16. Jiang, Y.-X., and L.-H. Wang. Unpublished observations.
17. Kalebic, T., M. Tsokos, and L. J. Helman. 1994. In vivo treatment with antibody against the IGF-I receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2. Cancer Res. 54:5531-5534.
18. 2. Proc. Natl. Acad. Sci. USA 94:11233-11237.
19. Lee, C.-T., S. Wu, D. Gabrilovich, H. Chen, N. Nadaf-Rahrov, I. F. Cieraik, and D. P. Carbone. 1996. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res. 56:3038-3041.
20. Li, S., A. Ferber, M. Miura, and R. Baserga. 1994. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J. Biol. Chem. 269:32558-32564.
21. Li, S., M. Resnicoff, and R. Baserga. 1996. Effect of mutations at serines 1280-1283 on the milogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:12254-12260.
22. Li, W., W. Li, X.-H. Cheo, C. A. Kelley, M. Alimandi, J. Zhang, Q. Chen, D. P. Bottaro, and J. H. Pierce. 1996. Identification of tyrosine 187 as a protein kinase C-δ phosphorylation site. J. Biol. Chem. 271:26404-26409.
23. Li, W., P. Michieli, M. Alimandi, M. V. Lorenzi, Y. Wu, L.-H. Wang, M. A. Heidaran, and J. H. Pierce. 1996. Expression of an ATP binding mutant of PKC-δ inhibits Sis-induced transformation of NIH3T3 cells. Oncogene 13:731-737.
24. Li, W., H. Mischak, J.-C. Yu, L.-M. Wang, J. F. Mushinski, M. A. Heidaran, and J. H. Pierce. 1994. Tyrosine phosphorylation of protein kinase C-δ in response to its activation. J. Biol. Chem. 269:2349-2352.
25. Li, W., and J. H. Pierce. 1996. Protein kinase C-δ, an important signaling molecule in the platelet-derived growth factor-β receptor pathway. Cur. Top. Microbiol. Immunol. 211:55-65.
26. Li, W., J.-C. Yu, P. Michieli, J. F. Beeler, N. Ellmore, M. A. Heidaran, and J. H. Pierce. 1994. Stimulation of the platelet-derived growth factor β receptor signaling pathway activates protein kinase C-δ. Mol. Cell. Biol. 14:6727-6735.
27. Li, W., J.-C. Yu, D.-Y. Shin, and J. H. Pierce. 1995. Characterization of a protein kinase C-δ (PKC-δ) ATP binding mutant: an inactive enzyme that competitively inhibits wild type PKC-δ enzymatic activity. J. Biol. Chem. 270:8311-8318.
28. Liao, L., K. Ramsey, and S. Jaken. 1994. Protein kinase C isozyme in progressively transformed rat fibroblasts. Cell Growth Differ. 5:1185-1194.
29. Liu, D., W. J. Rutter, and L.-H. Wang. 1992. Enhancement of transforming potential of human insulin-like growth factor I receptor N-terminal truncation and fusion to avian sarcoma virus. J. Virol. 66:374-385.
30. Liu, D., W. Rutter, and L.-H. Wang. 1993. Modulatory effects of the extra-cellular sequence of the human insulin-like growth I receptor on its transforming and tumorigenic potential. J. Virol. 67:9-18.
31. Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
32. Lu, Z., A. Hornia, Y.-W. Jiang, Q. Zang, S. Ohno, and D. A. Foster. 1997. Tumor promotion by depleting cells of protein kinase Cδ. Mol. Cell. Biol. 17:3418-3428.
33. Mischak, H., J. H. Pierce, J. Goodnight, M. G. Kazanietz, P. M. Blumberg, and J. F. Mushinski. 1993. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not protein kinase C-βII, -γ, -ξ, and -η. J. Biol. Chem. 268:20110-20115.
34. Miura, M., E. Surmacz, J.-L. Burgaud, and R. Baserga. 1995. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270:22639-22644.
35. Morrione, A., T. DeAngelis, and R. Baserga. 1995. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J. Virol. 69:5300-5303.
36. Neuenschwander, S., J. C. T. Roberts, and D. LeRoith. 1995. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor 1 receptor antisense ribonucleic acid. Endocrinology 136:4298-4303.
37. O'Connor, R., A. Kauffmann-Zeh, Y. Liu, S. Lehar, G. I. Evan, R. Baserga, and W. A. Blatter. 1997. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17:427-435.
38. Pass, H. I., D. J. W. Mew, M. Carbone, W. A. Matthews, J. S. Donington, R. Baserga, C. L. Walker, M. Resnkoff, and S. M. Steinberg. 1996. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor I receptor. Cancer Res. 56:4044-4048.
39. Pawson, T. 1995. Protein modules and signalling networks. Nature 373:573-580.
40. Poon, B., D. Dixon, L. Ellis, R. A. Roth, W. J. Rutter, and L.-H. Wang. 1991. Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras. Proc. Natl. Acad. Sci. USA 88:877-881.
41. Prager, D., H. L. Li, S. Asa, and S. Melmed. 1994. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor-I receptor mutant. Proc. Natl. Acad. Sci. USA 91:2181-2185.
42. Resnicoff, M., D. Coppola, C. Sell, R. Rubin, S. Ferrone, and R. Baserga. 1994. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54:4848-4850.
43. Sell, C., G. Dumenil, C. Devaud, M. Miura, D. Coppola, T. DeAngelis, R. Rubin, A. Efstratiadis, and R. Baserga. 1994. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604-3612.
44. Sell, C., M. Rubini, R. Rubin, J. P. Liu, A. Efstratiadis, and R. Baserga. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type I IGF receptor. Proc. Natl. Acad. Sci. USA 90:11217-11221.
45. Shapiro, D. N., B. G. Jones, L. H. Shapiro, P. Dias, and P. J. Houghton. 1994. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94:1235-1242.
46. Smith, H., E.-Y. Clung, Z. Szallasi, P. M. Blumberg, and J. Rivera. 1995. Tyrosine phosphorylation of protein kinase C-6 in response to the activation of the high-affinity receptor for immunoglobulin E modifies its substrate recognition. Proc. Natl. Acad. Sci. USA 92:9112-9116.
47. Soltoff, S. P., and A. Toker. 1995. CarbaehoK substance P, and phorbol ester promote the tyrosine phosphorylation of protein kinase C delta in salivary gland epithelial cells. J. Biol. Chem. 270:13490-13495.
48. Standaert, M., G. Bandyopadhyay, X. Zhou, L. Galloway, and R. Farese. 1996. Insulin stimulates phospholipase D-dependcnt phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes. Endocrinology 137:3014-3020.
49. Standaert, M., K. Musunuru, K. Yaniada, D. Cooper, and R. Farese. 1994. Insulin-stimulated phosphatidylcholine hydrolysis, diacylglycerol/protein kinase C signalling, and hexose transport in pertussis toxin-treated BC3H-1 myocyles. Cell Signal 6:707-716.
50. Trojan, J., T. R. Johnson, S. D. Rudin, J. Ilan, M. L. Tykocinski, and I. Ilan. 1993. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 256:94-97.
51. Ulrich, A., A. Gray, R. W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kathuria, E. Chen, S. Jacobs, U. Franke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503-2512.
52. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-211.
53. Zang, Q., Z. Lu, M. Curto, N. Barile, D. Shalloway, and D. A. Foster. 1997. Interaction between v-Src and protein kinase C δ in v-Src-transformed fibroblasts. J. Biol. Chem. 272:13275-13280.
54. Zong, C. S., J. L. K. Chan, S. K. Yang, and L.-H. Wang. 1997. Mutation of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation. J. Biol. Chem. 272:1500-1506.